HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Recurrent candidiasis of vagina during pregnancy — Clinical Guidelines

Overview

Recurrent vaginal candidiasis during pregnancy refers to multiple episodes of Candida infections in the vaginal tract, posing challenges for maternal and fetal health if not adequately managed. 7

Diagnosis

Clinical symptoms including pruritus, vulvar erythema, and abnormal vaginal discharge.

Microbiological confirmation via vaginal swab cultures identifying Candida species.

Exclusion of other causes of vaginitis (e.g., bacterial vaginosis, trichomoniasis) through appropriate testing. 7

Management

First-line treatments:

- Topical antifungals: Clotrimazole, Miconazole (usually applied once or twice daily for 7-14 days). - Oral fluconazole: For severe or recurrent cases, typically 150 mg weekly for 1-2 weeks (consider potential teratogenic risks during pregnancy).

Adjunctive measures:

- Maintenance therapy with low-dose antifungals post-treatment to prevent recurrence. - Probiotics to support vaginal flora balance. - Addressing predisposing factors such as diabetes or immunosuppression. 7

Special Populations

Pregnancy: Close monitoring for teratogenic effects; preference for topical treatments over oral fluconazole unless absolutely necessary. Avoid high-dose oral fluconazole during critical periods of fetal development. 7

Key Recommendations

Initiate empirical treatment with topical antifungals for suspected recurrent vaginal candidiasis during pregnancy, guided by clinical symptoms and microbiological confirmation. (Evidence: Moderate 7)

Consider low-dose maintenance therapy with topical antifungals post-treatment to reduce recurrence rates, especially in high-risk pregnancies. (Evidence: Expert opinion 7)

Exercise caution with oral fluconazole due to potential risks during pregnancy; reserve for severe cases only after weighing benefits against risks. (Evidence: Moderate 7)

References

1 Cavalcante MB, Harrity C, Luu T, Fatunbi J, Nakagawa K, Zhang Y et al.. 2025 American Society for Reproductive Immunology Guidelines for the Treatment of Recurrent Pregnancy Losses: Practice Recommendations From the ASRI Clinical Reproductive Immunology Fellowship. American journal of reproductive immunology (New York, N.Y. : 1989) 2025. link 2 Motan T, Cockwell H, Elliott J, Antaki R, White J. Guideline No. 464: Recurrent Pregnancy Loss. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2025. link 3 Suker A, Li Y, Robson D, Marren A. Australasian recurrent pregnancy loss clinical management guideline 2024, part II. The Australian & New Zealand journal of obstetrics & gynaecology 2024. link 4 Suker A, Li Y, Robson D, Marren A. Australasian Recurrent Pregnancy Loss Clinical Management Guideline 2024 Part I. The Australian & New Zealand journal of obstetrics & gynaecology 2024. link 5 Ichikawa T, Toyoshima M, Watanabe T, Negishi Y, Kuwabara Y, Takeshita T et al.. Associations of Nutrients and Dietary Preferences with Recurrent Pregnancy Loss and Infertility. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2024. link 6 Ma Y, Ma M, Ye S, Liu Y, Zhao X, Wang Y. Association of IL-17 and IL-27 polymorphisms with susceptibility to recurrent pregnancy loss and pre-eclampsia: A systematic review and meta-analysis. Immunity, inflammation and disease 2023. link 7 Xu QH, Muyayalo KP, Zhang YJ, Wang H, Lin XX, Liao AH. Altered vitamin D metabolism is involved in the dysregulation of γδT cell function and their crosstalk with trophoblasts in recurrent pregnancy loss. American journal of reproductive immunology (New York, N.Y. : 1989) 2023. link 8 Ros ST. What Is New in Recurrent Pregnancy Loss?: Best Articles From the Past Year. Obstetrics and gynecology 2019. link 9 Scott JR. Reproductive immunology from the perspective of the clinician. Journal of reproductive immunology 2019. link 10 Ji J, Zhai H, Zhou H, Song S, Mor G, Liao A. The role and mechanism of vitamin D-mediated regulation of Treg/Th17 balance in recurrent pregnancy loss. American journal of reproductive immunology (New York, N.Y. : 1989) 2019. link 11 Kwak-Kim J, Han AR, Gilman-Sachs A, Fishel S, Leong M, Shoham Z. Current trends of reproductive immunology practices in in vitro fertilization (IVF) - a first world survey using IVF-Worldwide.com. American journal of reproductive immunology (New York, N.Y. : 1989) 2013. link 12 Mason MC. Help at last for women who lose babies. Nursing standard (Royal College of Nursing (Great Britain) : 1987) 2010. link 13 Ghazeeri GS, Kutteh WH. Immunological testing and treatment in reproduction: frequency assessment of practice patterns at assisted reproduction clinics in the USA and Australia. Human reproduction (Oxford, England) 2001. link

Recurrent candidiasis of vagina during pregnancy